December 13, 2018

Around the nation: Gilead names former Roche exec as CEO

Daily Briefing

    Gilead Sciences' new CEO, Daniel O'Day, recently served as head of pharmaceuticals for Roche, in today's bite-sized hospital and health industry news from California, District of Columbia, and Kentucky.

    • California: Gilead Sciences this week named Daniel O'Day as CEO. O'Day succeeds John Milligan, who announced that he will resign at the end of 2018. O'Day recently served as head of pharmaceuticals for Roche (Paavola, Becker's Hospital Review, 12/11).

    • District of Columbia: Former President Barack Obama on Monday posted a video on Twitter that urged viewers to sign up for Affordable Care Act exchange plans before the current open enrollment period ends on Dec. 15. Obama also encouraged his followers to share the video, saying spreading the word about open enrollment "just might save a life" (Frank, CBS News, 12/10).

    • Kentucky: BrightSpring Health Services, a company that providers nonclinical services to patients with complex medical needs, and PharMerica, a pharmaceutical company, have announced plans to merge and create a health care company that will serve 44 states and Washington D.C. Jon Rousseau, president and CEO of BrightSpring, said the merger will combine the company's "community-based health services" with PharMerica's "pharmacy capabilities" to "drive improved patient outcomes and reduced costs." The companies have not determined a closing date (Larson, Louisville Business Journal, 12/11).

    Learn more: How to ensure seamless leadership transitions

    We spoke with an array of HR executives and discovered eight key insights your organization can use to build a strong, diverse executive team ready to meet current and future challenges. To learn more, read our briefing about how to ensure seamless leadership transitions.

    Download Now

    X
    Cookies help us improve your website experience. By using our website, you agree to our use of cookies.